1 hour ago
1
fadfebrian
- Nasus Pharma (NSRX), a company specializing in intranasal products, has set the price for its initial public offering at $8.00 per share, aiming to raise $10M through the sale of 1.25M shares.
- The company’s ordinary shares have received approval for listing on the NYSE American.
- Trading is anticipated to commence on the NYSE American on August 13, with the shares being listed under the ticker symbol "NSRX".
English (US) ·